ECS launches Woman Health Brand

Women now account for more than 40% of medicinal cannabis approvals under Australia’s Special Access Scheme Category B (SAS-B), highlighting a growing demand for treatments tailored to female health conditions. ECS has developed AVANI AVA in direct response to this trend, leveraging its vertically integrated operations and formulation expertise to deliver carefully designed products across a range